Endolytix Technology
Beverly, US · Founded 2020 · Delaware corporation
Find your way into Endolytix Technology
Sign up to see every warm intro you have to Endolytix Technology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Endolytix Technology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RZ
Ron ZwanzigerExecutive
RH
Ruoxi HuNamed on SEC filing
WN
Westley NolinNamed on SEC filing
JH
Jason HolderNamed on SEC filing
GM
Gary MagnantNamed on SEC filing
Board
RS
Richard SnyderBoard director
Reported raises · per SEC filings
Form D private placements$21.3M disclosed across 3 rounds · 2021–2024
▶$5MraisedAug 2024 · 3 investors · OtherRule 506(b)
▶$5MraisedAug 2024 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ruoxi HuExecutive Officer, Director
- Westley NolinExecutive Officer, Director
- Richard SnyderDirector
- Ron ZwanzigerExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $5M
- Minimum investment
- $1K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 04, 06b
▶$4.3MraisedSep 2023 · 14 investors · PharmaceuticalsRule 506(b)
▶$4.3MraisedSep 2023 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ron ZwanzigerDirector
- Westly NolinExecutive Officer, Director
- Rouxi HuExecutive Officer, Director
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- Minimum investment
- $1K
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 04, 06b
▶$12MraisedMar 2021 · 27 investors · BiotechnologyRule 506(b)
▶$12MraisedMar 2021 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason HolderDirector, Promoter
- Gary MagnantExecutive Officer, Director, Promoter
- Ron ZwanzigerExecutive Officer, Director, Promoter
- Offering amount
- $12M
- Amount sold
- $12M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Endolytix Technology raised?
- Endolytix Technology has disclosed $21.3M raised across 3 rounds.
- Where is Endolytix Technology headquartered?
- Endolytix Technology is headquartered in Beverly, US.